Journal article · Vestibular← The news desk

✦ The Dispatch

Immune heterogeneity and the immune-barrier-hydrops framework in Ménière's disease: current evidence, uncertainties, and testable hypotheses

A dispatch from PubMed — filed

Ménière's disease presents with episodic vertigo, fluctuating sensorineural hearing loss, tinnitus, and aural fullness, and commonly features endolymphatic hydrops. Yet similar hydropic phenotypes arise in patients with markedly different clinical courses, patterns of bilateral involvement, and treatment responses, suggesting that more than one upstream process may lead to hydrops....

Continue reading at PubMed

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No actionable clinical change at this time; this is a theoretical framework review that generates hypotheses but does not yet provide evidence to alter diagnosis or treatment of Ménière's disease.

✦ Why It Matters ✦

A unified immune-barrier-hydrops framework could reframe Ménière's disease research priorities and eventually open new immunological or barrier-targeted treatment pathways.

✦ Key Points ✦
  1. 01Proposes an 'immune-barrier-hydrops' framework linking immune dysfunction, blood-labyrinth barrier breakdown, and endolymphatic hydrops (inner-ear fluid buildup) in Ménière's disease.
  2. 02Highlights immune heterogeneity—meaning patients may have different immune subtypes—as a reason prior treatments have shown variable results.
  3. 03Published in Frontiers in Immunology (2026); represents a cross-disciplinary immunology–audiology perspective.
  4. 04Lists specific testable hypotheses to guide future basic and translational research.
  5. 05Does not present new primary data; synthesizes and reframes existing evidence.
✦ Claims & Evidence ✦

Immune heterogeneity among Ménière's disease patients contributes to variable treatment responses and disease progression.

opinionpartially supported

Breakdown of the blood-labyrinth barrier is a key mechanistic link between immune dysfunction and endolymphatic hydrops in Ménière's disease.

studyunclear
✦ Research metadata ✦
PMID
43041836
DOI
10.3389/fimmu.2026.1950826.
Journal
Frontiers in Immunology
Publication type
review
Evidence level
5
Population
Not applicable (narrative/theoretical review of Ménière's disease literature)
Intervention
Immune-barrier-hydrops conceptual framework applied to Ménière's disease pathophysiology

Primary outcomes

Synthesis of evidence for immune heterogeneity in Ménière's disease; Proposal of testable mechanistic hypotheses linking immunity, barrier function, and hydrops

✦ Related stories ✦